These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 430289)

  • 1. Impaired growth in hyperkinetic children receiving pemoline.
    Dickinson LC; Lee J; Ringdahl IC; Schedewie HK; Kilgore BS; Elders MJ
    J Pediatr; 1979 Apr; 94(4):538-41. PubMed ID: 430289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of stimulant medication on the growth of hyperkinetic children.
    Roche AF; Lipman RS; Overall JE; Hung W
    Pediatrics; 1979 Jun; 63(6):847-50. PubMed ID: 450520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on growth in pemoline-treated children with attention deficit disorder.
    Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A
    Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth disturbances in hyperkinetic children.
    Greenhill LL; Puig-Antich J; Halpern F; Sachar EJ; Rubinstein B; Chambers W; Fiscina B; Florea J
    Pediatrics; 1980 Jul; 66(1):152-4. PubMed ID: 7402783
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of stimulant drug research with hyperactive children.
    Barkley RA
    J Child Psychol Psychiatry; 1977 Apr; 18(2):137-65. PubMed ID: 326801
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth in children with acute lymphocytic leukemia: a Pediatric Oncology Group study.
    Berry DH; Elders MJ; Crist W; Land V; Lui V; Sexauer AC; Dickinson L
    Med Pediatr Oncol; 1983; 11(1):39-45. PubMed ID: 6572778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical EEG studies of short and long term stimulant drug therapy of hyperkinetic children.
    Small JG; Milstein V; Jay S
    Clin Electroencephalogr; 1978 Oct; 9(4):186-94. PubMed ID: 737854
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children.
    Safer DJ; Allen RP
    Pediatrics; 1973 Apr; 51(4):660-7. PubMed ID: 4697515
    [No Abstract]   [Full Text] [Related]  

  • 9. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP; Van Meter QL; Kowarski AA
    Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone--dependent growth failure.
    Frazer T; Gavin JR; Daughaday WH; Hillman RE; Weldon VV
    J Pediatr; 1982 Jul; 101(1):12-5. PubMed ID: 7086612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pemoline in serum by high performance liquid chromatography: clinical application to optimize treatment of hyperactive children.
    Tomkins CP; Soldin SJ; MacLeod SM; Rochefort JG; Swanson JM
    Ther Drug Monit; 1980; 2(3):255-60. PubMed ID: 7222180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pemoline on hyperactive boys.
    Knights RM; Viets CA
    Pharmacol Biochem Behav; 1975; 3(6):1107-14. PubMed ID: 772696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
    Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatomedin activity and cartilage [35S]sulphate incorporation in the growth-retarded neonatal rat.
    Fekete M; Hill DJ; Milner RD
    Biol Neonate; 1983; 44(2):114-22. PubMed ID: 6349705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Somatomedin and growth hormone in patients with retarded growth and atrophy due to congenital heart disease or malabsorption (author's transl)].
    Kerpel-Fronius E; Kiss S; Kardos G; Gács G
    Monatsschr Kinderheilkd (1902); 1977 Aug; 125(8):783-6. PubMed ID: 904638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ronyl (pemoline) in overactive mentally subnormal children.
    Spencer DA
    Br J Psychiatry; 1970 Aug; 117(537):239-40. PubMed ID: 4921176
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperkinetic syndrome and Tourette syndrome.
    Rapoport JL; Nee L; Mitchell S; Polinsky R; Ebert M
    Adv Neurol; 1982; 35():423-6. PubMed ID: 6959519
    [No Abstract]   [Full Text] [Related]  

  • 20. Pemoline in overactive mentally handicapped children.
    Triantafillou M
    Br J Psychiatry; 1972 Nov; 121(564):577. PubMed ID: 5084344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.